Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice

Liver fibrosis is a disease caused by long‐term damage that is related to a number of factors. The current research on the treatment of liver fibrosis mainly focuses on the activation of hepatic stellate cell, in addition to protecting liver cells. byakangelicin has certain anti‐inflammatory ability...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cell Mol Med
Autori principali: Li, Xiaohe, Shao, Shuaibo, Li, Hailong, Bi, Zhun, Zhang, Shanshan, Wei, Yiying, Bai, Jiakun, Zhang, Ruotong, Ma, Xiaoyang, Ma, Bowei, Zhang, Liang, Xie, Chunfeng, Ning, Wen, Zhou, Honggang, Yang, Cheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412405/
https://ncbi.nlm.nih.gov/pubmed/32643868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15493
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi